Acteurs : Acteur Jean FAIVRE

0

Nom

Pr Jean FAIVRE

Coordonnées

Pr Jean FAIVREInserm U866Registre Bourguignon des Cancers Digestifs FACULTE DE MEDECINE 7, Bd Jeanne d’Arc

21079 DIJON CEDEX

Tel : +33 3 80 39 33 40
e/m : [email protected]

Affiliation(s)

Equipe de recherche

 

Equipe B17 – Jean FAIVRE • Plate-forme Epidémiologie – Francis GUILLEMIN •

Aires d’expertise
Cancer:ColorectalClinique:Hépato-Gastro-EntérologiePlate-forme:EpidémiologieRecherche:Epidémiologie
Axes du CGE

1 : Indicateurs de santé et évaluation des pratiques en cancérologie

 

Projets

Equipe B17

2008 – PROMIS (porteur : Jean FAIVRE)
A Protein bioMarker Signature for Improving Colorectal Cancer Screening.

2007 – IGOR (porteur : Jean FAIVRE)
Comparison of guaiac and immunochemical faecal occult blood test in screening for colorectal cancer in an average risk population

 

 

 

Publications

 

Faivre J, Lepage C, Viguier J. [Colorectal cancer: From diagnosis to screening.] Gastroenterol Clin Biol. 2009 Aug 24.

 

Borie F, Niampa H, Bouvier AM, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Tretarre B. [Current management and prognosis of intrahepatic cholangiocarcinoma in France.] Gastroenterol Clin Biol. 2009 Jul 30.

 

Bouvier AM, Remontet L, Hedelin G, Launoy G, Jooste V, Grosclaude P, Belot A, Lacour B, Esteve J, Bossard N, Faivre J. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis. Cancer. 2009 Jun 30.

 

Lepage C, Ciccolallo L, De Angelis R, Bouvier A, Faivre J, Gatta G. European disparities in malignant digestive endocrine tumours survival. Int J Cancer. 2009 Jun 30.

 

David M, Lepage C, Jouve JL, Jooste V, Chauvenet M, Faivre J, Bouvier AM. Management and prognosis of pancreatic cancer over a 30-year period. Br J Cancer. 2009 Jul 21;101(2):215-8. Epub 2009 Jun 30.

 

Borie F, Tretarre B, Bouvier AM, Faivre J, Binder F, Launois G, Delafosse P, Tissot J, Peng J, Grosclaude P, Guizard AV, Gras-Aygon C. Primitive liver cancers: epidemiology and geographical study in France. Eur J Gastroenterol Hepatol. 2009 Apr 7.

 

Cheynel N, Cortet M, Lepage C, Ortega-Debalon P, Faivre J, Bouvier AM. Incidence, patterns of failure, and prognosis of perforated colorectal cancers in a well-defined population. Dis Colon Rectum. 2009 Mar;52(3):406-11.

 

Chauvenet M, Lepage C, Jooste V, Cottet V, Faivre J, Bouvier AM. Prevalence of patients with colorectal cancer requiring follow-up or active treatment. Eur J Cancer. 2009 May;45(8):1460-5. Epub 2009 Feb 11.

 

Binquet C, Abrahamowicz M, Astruc K, Faivre J, Bonithon-Kopp C, Quantin C. Flexible statistical models provided new insights into the role of quantitative prognostic factors for mortality in gastric cancer. J Clin Epidemiol. 2009 Mar;62(3):232-40. Epub 2008 Dec 12.

 

Latournerie M, Jooste V, Cottet V, Lepage C, Faivre J, Bouvier AM. Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg. 2008 Dec;95(12):1528-33.

 

Borie F, Bouvier AM, Herrero A, Faivre J, Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P, Tretarre B. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol. 2008 Dec 1;98(7):505-9.

 

Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, Rat P, Bouvier AM, Laurent-Puig P, Faivre J, Chapusot C, Piard F. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res. 2008 Oct 15;68(20):8541-6.

 

Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008 Nov;103(11):2694-9. Epub 2008 Oct 3.

 

Binquet C, Abrahamowicz M, Mahboubi A, Jooste V, Faivre J, Bonithon-Kopp C, Quantin C. Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy. Stat Med. 2008 Dec 30;27(30):6470-88.

 

Methy N, Binquet C, Boutron-Ruault MC, Paillot B, Faivre J, Bonithon-Kopp C. Dietary fatty acids and recurrence of colorectal adenomas in a European intervention trial. Nutr Cancer. 2008;60(5):560-7.

 

Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer. 2008 Oct;44(15):2254-8. Epub 2008 Aug 27.

 

Gatta G, Ciccolallo L, Faivre J, Bouvier AM, Berrino F, Gerard JP. Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study. J Cancer Surviv. 2007 Dec;1(4):247-54. Epub 2007 Sep 27.

 

Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinie F, Danzon A, Bara S, Bouvier AM, Tretarre B, Binder-Foucard F, Colonna M, Daubisse L, Hedelin G, Launoy G, Le Stang N, Maynadie M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Cherie-Challine L, Esteve J, Remontet L, Velten M. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-75. Epub 2008 Jun 10.

 

Bouvier AM, Jooste V, Bonnetain F, Cottet V, Bizollon MH, Bernard MP, Faivre J. Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: a population-based study. Cancer. 2008 Aug 15;113(4):879-86.

 

de Reynies A, Boige V, Milano G, Faivre J, Laurent-Puig P. KRAS mutation signature in colorectal tumors significantly overlaps with the cetuximab response signature. J Clin Oncol. 2008 May 1;26(13):2228-30; author reply 2230-1.

 

Cottet V, Jooste V, Bouvier AM, Michiels C, Faivre J, Bonithon-Kopp C. Time trends in first-diagnosis rates of colorectal adenomas: a 24-year population-based study. Aliment Pharmacol Ther. 2008 May;27(10):950-9. Epub 2008 Mar 5.

 

Legras A, Lievre A, Bonaiti-Pellie C, Cottet V, Pariente A, Nalet B, Lafon J, Faivre J, Bonithon-Kopp C, Goasguen N, Penna C, Olschwang S, Laurent-Puig P. Mitochondrial D310 mutations in colorectal adenomas: an early but not causative genetic event during colorectal carcinogenesis. Int J Cancer. 2008 May 15;122(10):2242-8.

 

Clerc L, Jooste V, Lejeune C, Schmitt B, Arveux P, Quantin C, Faivre J, Bouvier AM. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Eur J Health Econ. 2008 Nov;9(4):361-7. Epub 2007 Nov 21.

 

Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006 Aug;244(2):254-9.

 

Lepage C, Bouvier AM, Binquet C, Dancourt V, Coatmeur O, Faivre J. Are the recommendations of the French consensus conference on the management of colon cancer followed up? Eur J Cancer Prev. 2006 Aug;15(4):295-300.

 

Bouvier AM, Binquet C, Gagnaire A, Jouve JL, Faivre J, Bedenne L. Management and prognosis of esophageal cancers: has progress been made? Eur J Cancer. 2006 Jan;42(2):228-33. Epub 2005 Dec 7.

 

Bouvier AM, Launoy G, Lepage C, Faivre J. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther. 2005 Aug 1;22(3):233-41.

 

Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, Roignot P, Arnould L, Beaune P, Faivre J, Laurent-Puig P. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005 May 20;23(15):3517-25.

 

Hatem C, Minello A, Bresson-Hadni S, Jooste V, Evrard P, Obert B, Lepage C, Bonithon-Kopp C, Faivre J, Monnet E, Miguet JP, Hillon P. Is the management of hepatitis C patients appropriate? A population-based study. Aliment Pharmacol Ther. 2005 Apr 15;21(8):1007-15.

 

Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005 May;16(5):756-61. Epub 2005 Mar 24.

 

Lejeune C, Arveux P, Dancourt V, Bejean S, Bonithon-Kopp C, Faivre J. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer. Int J Technol Assess Health Care. 2004 Fall;20(4):434-9.

 

Chapusot C, Martin L, Puig PL, Ponnelle T, Cheynel N, Bouvier AM, Rageot D, Roignot P, Rat P, Faivre J, Piard F. What is the best way to assess microsatellite instability status in colorectal cancer? Study on a population base of 462 colorectal cancers. Am J Surg Pathol. 2004 Dec;28(12):1553-9.

 

Bouvier AM, Remontet L, Jougla E, Launoy G, Grosclaude P, Buemi A, Tretarre B, Velten M, Dancourt V, Menegoz F, Guizard AV, Mace Lesec’h J, Peng J, Bercelli P, Arveux P, Esteve J, Faivre J. Incidence of gastrointestinal cancers in France. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):877-81.

 

Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004 Jun;126(7):1674-80.

 

Phelip JM, Launoy G, Colonna M, Grosclaude P, Velten M, Danzon A, Raverdy N, Tretarre B, Bouvier AM, Faivre J. Regional variations in management of rectal cancer in France. Gastroenterol Clin Biol. 2004 Apr;28(4):378-83.

 

Ponnelle T, Chapusot C, Martin L, Bonithon-Kopp C, Bouvier AM, Plenchette S, Rageot D, Faivre J, Solary E, Piard F. Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis. Pathol Res Pract. 2003;199(11):723-31.

 

Lejeune C, Arveux P, Dancourt V, Fagnani F, Bonithon-Kopp C, Faivre J. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer. Eur J Cancer Prev. 2003 Feb;12(1):77-84.

 

Chapusot C, Martin L, Bouvier AM, Bonithon-Kopp C, Ecarnot-Laubriet A, Rageot D, Ponnelle T, Laurent Puig P, Faivre J, Piard F. Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas. Br J Cancer. 2002 Aug 12;87(4):400-4.

 

Bonithon-Kopp C, Kronborg O, Giacosa A, Rath U, Faivre J. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet. 2000 Oct 14;356(9238):1300-6.